Verition Fund Management LLC decreased its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 60.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 19,634 shares of the company’s stock after selling 29,538 shares during the quarter. Verition Fund Management LLC’s holdings in Option Care Health were worth $615,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of the stock. Martingale Asset Management L P purchased a new stake in shares of Option Care Health during the third quarter worth approximately $287,000. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Option Care Health by 84.6% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 70,119 shares of the company’s stock worth $2,195,000 after acquiring an additional 32,142 shares in the last quarter. FORA Capital LLC purchased a new stake in shares of Option Care Health in the 3rd quarter valued at approximately $1,178,000. CreativeOne Wealth LLC raised its holdings in shares of Option Care Health by 21.9% in the 3rd quarter. CreativeOne Wealth LLC now owns 14,380 shares of the company’s stock valued at $450,000 after purchasing an additional 2,585 shares in the last quarter. Finally, Townsquare Capital LLC raised its holdings in shares of Option Care Health by 6.2% in the 3rd quarter. Townsquare Capital LLC now owns 72,675 shares of the company’s stock valued at $2,275,000 after purchasing an additional 4,258 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.
Analysts Set New Price Targets
Several equities analysts recently commented on OPCH shares. Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and dropped their target price for the company from $38.00 to $26.00 in a report on Thursday, October 31st. UBS Group assumed coverage on Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price objective on the stock. Truist Financial cut their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. Barrington Research lowered their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a report on Thursday, October 31st. Finally, JMP Securities raised their price objective on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a report on Monday, September 30th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, Option Care Health has a consensus rating of “Hold” and an average target price of $30.14.
Insider Transactions at Option Care Health
In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of Option Care Health stock in a transaction dated Friday, November 8th. The stock was acquired at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the acquisition, the director now owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.64% of the company’s stock.
Option Care Health Trading Up 2.7 %
NASDAQ:OPCH opened at $23.86 on Wednesday. The company has a market capitalization of $4.06 billion, a PE ratio of 19.40, a P/E/G ratio of 2.37 and a beta of 1.33. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $34.63. The stock’s 50 day moving average price is $25.88 and its 200 day moving average price is $28.62. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.
Option Care Health Profile
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Articles
- Five stocks we like better than Option Care Health
- Top Biotech Stocks: Exploring Innovation Opportunities
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- What is a Low P/E Ratio and What Does it Tell Investors?
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- What is a Secondary Public Offering? What Investors Need to Know
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.